TrialBlood advances2019
Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL.
Paolo Strati et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it